The UMass Chan Medical School Department of Microbiology and Physiological Systems is now the Department of Microbiology, according to Beth McCormick, PhD.  

Researchers in UMass Chan Medical School’s Center for Microbiome Research are exploring the causal mechanisms by which bacteria in the gut influence chronic illnesses such as Alzheimer’s and Crohn’s disease and in autoimmune disorders and other conditions.

The UMass Chan Medical School light microscopy core facility, Sanderson Center for Optical Experimentation, announced a new collaboration with Leica Microsystems.

Beth A. McCormick, PhD, has been named the new chair of the Department of Microbiology & Physiological Systems (MaPS), and Michael P. Stauff, MD, has been appointed chair of the Department of Orthopedics & Physical Rehabilitation.

Beth McCormick, PhD, and Vanni Bucci, PhD, are leading a $3 million effort to explore engineering the gut microbiome to counteract the effects of radiation exposure and total body irradiation.

After college, MD/PhD student Ethan Loew was torn between practicing bench science or becoming a clinician, but his postgraduate experience in a lab and a hospital showed him how he could combine the two.

New research by Kaleido Biosciences, Inc., and UMass Medical School’s John P. Haran, MD, PhD, and Beth McCormick, PhD, shows that the company’s microbiome metabolic therapy candidate produced positive results in patients with mild-to-moderate COVID-19.

Discoveries made by Beth McCormick, PhD, and licensed by Bacainn Therapeutics, Inc. are heading to Phase I clinical trials for ulcerative colitis and other diseases associated with uncontrolled inflammation in the gut.